- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
Texas Mobile Health buys Adaptive Video
Mobile mammography company Texas Mobile Health of Houston is acquiringsystems connectivity developer Adaptive Video of Novato, CA. TexasMobile Health says it plans to use Adaptive Video's connectivityprowess to help link its facilities as the company
Mobile mammography company Texas Mobile Health of Houston is acquiringsystems connectivity developer Adaptive Video of Novato, CA. TexasMobile Health says it plans to use Adaptive Video's connectivityprowess to help link its facilities as the company expands.
Adaptive Video's Remote Access Image Management InformationSystem (RAIMIS) includes AD/V 1.5, a video framegrabber, and AD/VSpooler, a printer spooler. The company is moving from point-to-pointconnectivity solutions into networked connectivity with ImagePlex,a PC-based system for connecting legacy imaging devices with anetwork. ImagePlex recently received 510(k) clearance and willbe offered direct and through OEMs.
Texas Mobile Health runs four mobile mammography routes inTexas and Mississippi, and has aggressive plans for expandinginto other types of preventive services and other geographic regions,according to founder and president Chelette Baker.
Under the terms of the acquisition, the Texas Mobile Healthand Adaptive Video names will be retired and the companies willbe folded into a new firm, Basic Solutions International. TheAdaptive Video operations will focus on the technical developmentof imaging devices while the Texas Mobile Health business willprovide healthcare services. Basic Solutions will maintain headquartersin Novato and Houston.
Mammography Study Suggests DBT-Based AI May Help Reduce Disparities with Breast Cancer Screening
December 13th 2024New research suggests that AI-powered assessment of digital breast tomosynthesis (DBT) for short-term breast cancer risk may help address racial disparities with detection and shortcomings of traditional mammography in women with dense breasts.
Study Shows Merits of CTA-Derived Quantitative Flow Ratio in Predicting MACE
December 11th 2024For patients with suspected or known coronary artery disease (CAD) without percutaneous coronary intervention (PCI), researchers found that those with a normal CTA-derived quantitative flow ratio (CT-QFR) had a 22 percent higher MACE-free survival rate.
Can MRI-Based AI Bolster Biopsy Decision-Making in PI-RADS 3 Cases?
December 9th 2024In patients with PI-RADS 3 lesion assessments, the combination of AI and prostate-specific antigen density (PSAD) level achieved a 78 percent sensitivity and 93 percent negative predictive value for clinically significant prostate cancer (csPCa), according to research presented at the Radiological Society of North American (RSNA) conference.
Assessing MACE Risk in Women: Can an Emerging Model with SPECT MPI Imaging Have an Impact?
December 9th 2024In research involving over 2,200 women who had SPECT MPI exams, researchers found that those who had a high score with the COronary Risk Score in WOmen (CORSWO) model had a greater than fourfold higher risk of major adverse coronary events (MACE).
